SEW-2871,
SEW2871,
SEW2871,
256414-75-2,
SEW 2871,
5-[4-Phenyl-5-(trifluoromethyl)-2-thienyl]-3-[3-(trifluoromethyl)phenyl]-1,2,4-oxadiazole,
SEW-2871,
5-(4-Phenyl-5-(trifluoromethyl)thiophen-2-yl)-3-(3-(trifluoromethyl)phenyl)-1,2,4-oxadiazole,
CHEMBL224720,
S1P1 Receptor Agonist, SEW2871,
MFCD00096600,
Sphingosine-1-Phosphate1 Receptor S1P1 Agonist,
5-[4-phenyl-5-(trifluoromethyl)thiophen-2-yl]-3-[3-(trifluoromethyl)phenyl]-1,2,4-oxadiazole,
5-(4-Phenyl-5-trifluoromethylthiophen-2-yl)-3-(3-trifluoromethylphenyl)-(1,2,4)-oxadiazole,
AC1N2UY4,
SCHEMBL436150,
C20H10F6N2OS,
GTPL2926,
CHEBI:92283,
CTK7B7082,
DTXSID80399085,
HMS3268H16,
HMS3649L06,
HMS3677C06,
ZINC2141876,
1445AH,
BDBM50158345,
BS0178,
IN1083,
AKOS015853139,
AN-5811,
API0008462,
MCULE-6471887459,
RTC-030230,
TRA0003711,
NCGC00092356-01,
NCGC00092356-02,
ACM256414752,
AJ-33564,
AK-34387,
CC-21023,
CJ-32923,
SEW2871, >=98% (HPLC), solid,
DB-006928,
TC-030230,
B7001,
FT-0080687,
FT-0602670,
C-27359,
SR-01000695417,
J-016085,
SR-01000695417-1,
SR-01000695417-2,
BRD-K15601958-001-01-3,
BRD-K15601958-001-02-1,
I14-58432,
5-[4-Phenyl-5-(trifluoromethyl)-2-thienyl]-3-[3-(trifluoromethyl) phenyl]-1,2,4-oxadiazole,
5-[4-Phenyl-5-(trifluoromethyl)-2-thienyl]-3-[3-(trifluoromethyl)phenyl]- 1,2,4-oxadiazole,
5-[4-PHENYL-5-(TRIFLUOROMETHYL)THIEN-2-YL]-3-[3-(TRIFLUOROMETHYL)PHENYL]-1,2,4-OXADIAZOLE,
5-[4-Phenyl-5-(trifluoromethyl)thiophen-2-yl]-3-[3-(trifluoromethyl)phenyl]1,2,4-oxadiazole,
nchembio804-comp3,
D0ZU0O,
OYMNPJXKQVTQTR-UHFFFAOYSA-N,
CID4077460,
C503964,